| Japanese Journal of Clinical Oncology | Pages |
Introduction
Case Report
Pathological Findings
Macroscopic Findings
Microscopic Findings
Immunohistochemical Analysis
Discussion
Acknowledgments
References
Metaplastic Shadow Cells in Rectal Adenocarcinoma: Report of a Case with Immunohistochemical Study
We report a case of adenocarcinoma of the rectum with foci of metaplastic shadow cells. The patient was a 65 year old man with anemia. Macroscopically the tumor was an ordinary rectal cancer. Microscopically, in addition to the features of moderately differentiated adenocarcinoma invading the subserosa, islands of shadow cells in tumor nests were detected in both primary and one of three pericolic metastatic lymph node lesions. Neoplastic glandular cells showed gradual transition to shadow cells. An antibody specific for high-molecular-weight cytokeratins reacted with the shadow cells and intermediate zone epithelial cells surrounding them, but no CEA, low-molecular-weight cytokeratins or cyclin D1 was detectable in them. Cytokeratin 14 was expressed only in the transitional zone epithelial cells. The intermediate zone epithelial cells were regarded as metaplastic squamous cells, from which the shadow cells were derived. The patient died of multiple liver metastases nine and a half months after surgery. To our knowledge, this is the first report of an immunohistochemical study of rectal adenocarcinoma containing shadow cells not only in the primary lesion but also in a metastatic lymph node.
INTRODUCTION
Adenocarcinomas of the colorectum are malignant tumors arising from the crypt epithelium (1). Ordinarily the histological type is moderately to well differentiated adenocarcinoma (1). Nevertheless, many primary adenosquamous carcinomas and pure squamous cell carcinomas have been reported and some of them have been subjected to extensive clinicopathological study (2-4). Squamous cell carcinoma of the colorectum appears to be comparable with adenocarcinoma of the colorectum in terms of clinical behavior (5), but adenosquamous carcinoma in the colorectum tends to be more aggressive, the squamous component showing the greater metastatic potential (2,5).
In the present report we describe a case of rectal adenocarcinoma containing foci of metaplastic shadow cells. Apart from this single case, we have found only two other similar examples in the English literature (6).
CASE REPORT
A 65 year old man with anemia was admitted to the Department of Surgery, Yoshijima Hospital, Hiroshima, on May 30, 1994. A barium enema study demonstrated narrowing of the rectum and a colonoscopic examination revealed a large ulcerative lesion in the rectum above the peritoneal reflection, suggesting advanced rectal cancer. The preoperative serum level of CEA, 1.6 ng/ml, was within normal limits (normal range: <2.5 ng/ml, by radioimmunoassay). A biopsy specimen revealed features of moderately differentiated adenocarcinoma. Low anterior resection was performed on June 10, 1994, and the patient was discharged on July 5, 1994. However, a radiological and ultrasonographical examination revealed multiple liver metastases and the patient was re-admitted on January 27, 1995. The patient's serum CEA level rose to 31.4 ng/ml (normal range: <5.0 ng/ml, by enzyme immunoassay). The patient died of hepatic failure on March 24, 1995. Neither autopsy nor necropsy was performed. The patient's serum level of SCC, a tumor marker specific for squamous cell carcinoma (7), was not measured.
Pathological Findings
Macroscopic Findings
The resected rectal tumor, measuring 4.5 ×; 4.0 ×; 1.0 cm, was a well circumscribed elevated tumor with central ulceration (Fig.
Figure 1. Resected rectal tumor, measuring 4.5 × 4.0 × 1.0 cm, showing ulceration with raised everted edges.
Figure 2. Cut surfaces of the tumor. The tumor invades the subserosa and shows pericolic lymph node metastases.
Microscopic Findings
In the primary tumor, the predominant histologic features were those of moderately differentiated adenocarcinoma. The neoplastic cells had vesicular nuclei and showed irregular tubular structures including a cribriform pattern (Fig.
Figure 3. Neoplastic glandular epithelia showing a predominantly tubular and cribriform pattern.
Figure 4. Gradual transition of neoplastic glandular epithelia to the shadow cells. Intermediate zone epithelial cells have abundant eosinophilic or amphophilic cytoplasm and relatively regular nuclei (arrowheads). The shadow cells have eosinophilic cytoplasm and unstained shadows at the site of lost nuclei (arrows).
Figure 5. Shadow cells directly attached to the stroma.
Figure 6. Shadow cell nest surrounded by foreign body giant cells.
Figure 7. Shadow cell nest surrounded by foamy cells.
Figure 8. Large nodule composed of shadow cells in one lymph node metastatic lesion.
Immunohistochemical Analysis
To elucidate the nature of the shadow cells and the transitional intermediate epithelial cells facing them, we performed immunohistochemical staining. The antibodies used are listed in Table . Immunostaining for CKL, CK14 and CKH. (a) Neoplastic glandular cells are positive for CKL. (b) Intermediate zone epithelial cells directly surrounding the shadow cells show immunoreactivity for CK14. (c) The shadow cells express CKH. Table Table
Antibody
Specificity
Source
CAM5.2
Cytokeratins 8, 18, and 19 (low-molecular- weight cytokeratins: CKL)
Nippon Becton Dickinson Tokyo
C34903
Cytokeratins 1, 5, 10, and 11 (high-molecular- weight CKs: CKH)
Enzo Biochemicals, New York, NY
LL002
Cytokeratin 14
Novocastra, Newcastle, United Kingdom
II-7
CEA
DAKO Japan, Kyoto
CM1*
p53
Novocastra, Newcastle, United Kingdom
P2D11F11
Cyclin D1
Novocastra, Newcastle, United Kingdom
Cell types
CKL
CKH
CK14
CEA
p53
cyclin D1
Neoplastic glandular
+
-
-
+
-
+
(focal)
Intermediate zone
-
+
+
-
-
-
epithelial
Shadow
-
+
-
-
-
-
DISCUSSION
Shadow cells, also referred to as ghost cells, are cornified cells that, when stained in section by hematoxylin-eosin, appear as pale eosinophilic cells with distinct borders with poorly stained round zones in their centers, i.e., shadows or ghosts of nuclei (karyolysis), resulting from faulty attempts to form hair shafts (8). Shadow cells have been described as occurring not only in pilomatricoma but also in basal cell carcinoma (9), trichoepithelioma (conventional and desmoplastic types) (8), mixed tumors of the skin (8,10), adnexal carcinoma (10), intracranial dermoid cyst (11), endometrial adenocarcinoma with squamous metaplasia (12,13), ovarian adenocarcinoma with squamous metaplasia (13), atypical endometrial hyperplasia with squamous metaplasia (6), colonic adenocarcinoma with squamous metaplasia (6), pilomatricoma of the testicle (14) and transitional cell carcinoma of the urinary bladder (15). As shown in Table
In the present case, epithelial cells adjacent to the shadow cells showed transition to neoplastic glandular cells and a positive immunoreaction for CK14, but did not express CKL or CEA. Generally, CK14 is expressed in the cytoplasm of squamous epithelium and myoepithelial cells but not in that of glandular epithelium (16). In fact, the neoplastic glandular cells in the present study were negative for CK14. The antibody C34903 against CKH reacts with all squamous and ductal epithelium and stains carcinoma as much as squamous cell carcinoma and adenocarcinoma of ductal origin (e.g., breast, pancreas). In the present study, both the transitional zone epithelial cells and the shadow cells were reactive with C34903 but the neoplastic glandular cells were not. CAM5.2 recognizes CK8 and CK18, which are not expressed in stratified squamous epithelium and some squamous cell carcinomas. One report has described that CAM5.2 also detects CK19 (17). It is said that cyclin D1 expression represents a common feature of malignancies of diverse histogenesis (18). In the present case, the neoplastic glandular cells showed immunostaining for cyclin D1, whereas the intermediate zone epithelial cells around the shadow cells did not. These results strongly suggest that the intermediate zone epithelial cells were metaplastic squamous cells, from which the shadow cells had developed. Although one report has maintained that shadow cells serve as an important clue to follicular differentiation (8), those in the present case were not surrounded by matrix cells. In addition, calcification was not seen in association with the shadow cells. Therefore, we could not regard the shadow cells as evidence of matrix differentiation in the present tumor.
Table
Investigators
Age
Sex
Site
Tumor extension
Zamecnik et al. (6)
63
M
Sigmoid
colonLocally extensive and
inoperable tumor without
distant metastasis (clinically)
Zamecnik et al. (6)
58
M
ND
Infiltration of deep submucosa
without metastasis
Present case
65
M
Rectum
Infiltration of deep subserosa
with lymph node metastasis
Interestingly, peritoneal keratin granulomas, composed of ghost squamous cell fragments and foreign body-type giant cells with few or no viable carcinoma cells, have no association with the prognosis of patients with adenocarcinoma of the uterus or ovary showing squamous differentiation (12,13).
Judging from reports on uterine and ovarian carcinomas (11,12), the present type of colorectal adenocarcinoma may appear comparable with ordinary adenocarcinoma. To elucidate the prognostic significance of the shadow cells in adenocarcinoma of the colorectum, accumulation of similar cases and clinicopathological studies is needed.
Acknowledgments
The authors are grateful to Prof. Paul D. Andrew, Division of Physical Therapy, Institute of Health Sciences, Hiroshima University School of Medicine, for reading through the manuscript, and Mr Chitoshi Hidaka, Clinical Laboratory Department, Yoshijima Hospital, Hiroshima and Mr Masatoshi Shirota, Medical Research Center, Kochi Medical School, for excellent technical assistance.
References
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 19 May 1998
Copyright© Japanese Journal of Clinical Oncology, 1997.
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 19 May 1998
Copyright© Japanese Journal of Clinical Oncology, 1997.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This Article ![]()
![]()
Abstract
![]()
FREE Full Text (PDF)
![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in ISI Web of Science
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Add to My Personal Archive
![]()
Download to citation manager
![]()
Search for citing articles in:
ISI Web of Science (1)
![]()
Request Permissions
![]()
Google Scholar ![]()
![]()
Articles by Nakayama, H.
![]()
Articles by Enzan, H.
![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Nakayama, H.
![]()
Articles by Enzan, H.
![]()
Social Bookmarking ![]()
![]()
What's this?